KROS Operating Cash Flow (Statement)
Keros Therapeutics Inc · Operating Cash Flow (Statement)
KROS Operating Cash Flow (Statement)
Latest reported-$20.42Mperiod ending
KROS Quarterly Cash from Operations (-$2.51M → -$20.42M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
KROS operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -20,421,000 | |
| -3,529,000 | |
| -27,292,000 | |
| 3,249,000 | |
| -29,623,000 | |
| 161,171,000 | |
| -46,008,000 | |
| -30,500,000 | |
| -39,801,000 | |
| -44,560,000 | |
| -25,459,000 | |
| -33,982,000 | |
| -30,832,000 | |
| -34,235,000 | |
| -21,443,000 | |
| -24,602,000 | |
| -22,590,000 | |
| -1,427,000 | |
| -19,565,000 | |
| -14,441,000 | |
| -17,637,000 | |
| -10,505,000 | |
| -7,991,000 | |
| -10,856,000 | |
| -9,927,000 | |
| -8,120,000 | |
| -5,498,000 | |
| -2,955,000 | |
| -5,032,000 | |
| -2,513,000 |